收费全文 | 1252篇 |
免费 | 61篇 |
国内免费 | 2篇 |
耳鼻咽喉 | 4篇 |
儿科学 | 30篇 |
妇产科学 | 14篇 |
基础医学 | 157篇 |
口腔科学 | 14篇 |
临床医学 | 204篇 |
内科学 | 425篇 |
皮肤病学 | 10篇 |
神经病学 | 39篇 |
特种医学 | 127篇 |
外科学 | 73篇 |
综合类 | 16篇 |
预防医学 | 111篇 |
眼科学 | 4篇 |
药学 | 45篇 |
中国医学 | 2篇 |
肿瘤学 | 40篇 |
2023年 | 4篇 |
2021年 | 12篇 |
2020年 | 15篇 |
2019年 | 15篇 |
2018年 | 17篇 |
2017年 | 15篇 |
2016年 | 13篇 |
2015年 | 9篇 |
2014年 | 25篇 |
2013年 | 37篇 |
2012年 | 47篇 |
2011年 | 51篇 |
2010年 | 45篇 |
2009年 | 54篇 |
2008年 | 81篇 |
2007年 | 77篇 |
2006年 | 78篇 |
2005年 | 78篇 |
2004年 | 51篇 |
2003年 | 47篇 |
2002年 | 29篇 |
2001年 | 31篇 |
2000年 | 39篇 |
1999年 | 33篇 |
1998年 | 25篇 |
1997年 | 21篇 |
1996年 | 18篇 |
1995年 | 18篇 |
1994年 | 9篇 |
1993年 | 14篇 |
1992年 | 28篇 |
1991年 | 17篇 |
1990年 | 18篇 |
1989年 | 22篇 |
1988年 | 25篇 |
1987年 | 28篇 |
1986年 | 27篇 |
1985年 | 17篇 |
1984年 | 11篇 |
1983年 | 13篇 |
1982年 | 6篇 |
1981年 | 10篇 |
1980年 | 14篇 |
1979年 | 7篇 |
1978年 | 10篇 |
1977年 | 16篇 |
1976年 | 10篇 |
1975年 | 7篇 |
1973年 | 3篇 |
1968年 | 4篇 |
Challenges lie in finding the optimal balance between the risk of bleeding and preventing thrombotic complications such as reinfarction or stent thrombosis. During the last decade, bivalirudin was introduced as a valid alternative to heparin for patients undergoing primary percutaneous coronary intervention. Several trials have been conducted to identify the agent with the best antithrombotic results at the lowest bleeding complication rate. In a rapidly evolving field with changes in vascular access, available P2Y12 inhibitors, and indications for glycoprotein IIb/IIIa inhibitor administration, conflicting evidence became available.
Areas covered: This paper mainly focuses on the evidence above and gives brief discussion to the recent literature on anticoagulation in fibrinolytic therapy and advances in antiplatelet therapy.
Expert opinion: To date, no robust evidence is available challenging unfractionated heparin as the primary choice for anticoagulation in patients presenting with ST-segment elevation myocardial infarction. Further research should include efforts to refine anticoagulation strategies on an individual patient level. For patients undergoing primary percutaneous coronary intervention, bivalirudin could be used as an alternative to unfractionated heparin, while enoxaparin or fondaparinux is an alternative agent for patients treated with fibrinolytic therapy. 相似文献
Introduction
Left ventricular (LV) thrombus formation is a feared complication of myocardial infarction (MI). We assessed the prevalence of LV thrombus in ST-segment elevated MI patients treated with percutaneous coronary intervention (PCI) and compared the diagnostic accuracy of transthoracic echocardiography (TTE) to cardiovascular magnetic resonance imaging (CMR). Also, we evaluated the course of LV thrombi in the modern era of primary PCI.Methods
200 patients with primary PCI underwent TTE and CMR, at baseline and at 4 months follow-up. Studies were analyzed by two blinded examiners. Patients were seen at 1, 4, 12, and 24 months for assessment of clinical status and adverse events.Results
On CMR at baseline, a thrombus was found in 17 of 194 (8.8%) patients. LV thrombus resolution occurred in 15 patients. Two patients had persistence of LV thrombus on follow-up CMR. On CMR at four months, a thrombus was found in an additional 12 patients. In multivariate analysis, thrombus formation on baseline CMR was independently associated with, baseline infarct size (g) (B = 0.02, SE = 0.02, p < 0.001). Routine TTE had a sensitivity of 21–24% and a specificity of 95–98% compared to CMR for the detection of LV thrombi. Intra- and interobserver variation for detection of LV thrombus were lower for CMR (κ = 0.91 and κ = 0.96) compared to TTE (κ = 0.74 and κ = 0.53).Conclusion
LV thrombus still occurs in a substantial amount of patients after PCI-treated MI, especially in larger infarct sizes. Routine TTE had a low sensitivity for the detection of LV thrombi and the interobserver variation of TTE was large. 相似文献We have studied the effect of ergotamine tartrate (10